
Obayashi Corporation
OBYCFOTCIndustrials● Active
$19.00
$-0.70(-3.55%)
Market Cap$13.1B
P/E Ratio—
52W High$29.565
52W Low$13.83
Obayashi Corporation(OBYCF)· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · OBYCF · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.175T | $0.211T | $0.107T | $0.078T | $0.039T |
| Depreciation & Amort. | $0.037T | $0.032T | $0.027T | $0.024T | $0.020T |
| Stock-Based Comp. | $0.000T | $0.000T | $0.000T | $0.000T | $0.000T |
| Change in Working Capital | $0.096T | ($0.076T) | ($0.027T) | $0.128T | $0.036T |
| Net Cash from Operations | $0.255T | $0.086T | $0.050T | $0.228T | $0.070T |
| Investing Activities | |||||
| Capital Expenditure | ($0.126T) | ($0.050T) | ($0.078T) | ($0.097T) | ($0.058T) |
| Purchases of Investments | ($0.044T) | ($0.051T) | ($0.025T) | ($0.019T) | ($0.031T) |
| Sales of Investments | $0.103T | $0.113T | $0.060T | $0.042T | $0.044T |
| Net Cash from Investing | ($0.084T) | $0.010T | ($0.084T) | ($0.102T) | ($0.050T) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.058T) | ($0.012T) | ($0.000T) | ($0.000T) | ($0.001T) |
| Dividends Paid | ($0.058T) | ($0.067T) | ($0.030T) | ($0.027T) | ($0.023T) |
| Debt Issued / Repaid | ($0.025T) | $0.034T | ($0.020T) | $0.052T | $0.008T |
| Net Cash from Financing | ($0.144T) | ($0.051T) | ($0.052T) | $0.022T | ($0.012T) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.128T | $0.035T | ($0.028T) | $0.132T | $0.012T |
| FCF Margin %(computed) | 4.92% | 1.35% | -1.20% | 6.65% | 0.61% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · JPY · T
深入了解Obayashi Corporation
关于Obayashi Corporation(OBYCF)现金流量表
Obayashi Corporation 2026财年经营活动现金流$254.51B,自由现金流$128.09B(FCF利润率4.92%),资本支出($126.42B)。
常见问题
OBYCF · 4 问Obayashi Corporation 2026财年自由现金流$128.09B,同比up261.4%。
OBYCF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10